These Terms and Conditions govern the sale of Products to another (“Buyer”) by Avient Cor- poration and its affiliates (“Seller”). 1. Udlevering af en prøve eller udviklingsmateriale udgør ikke en tilladelse, anbefaling eller tilskyndelse til at udøve en patenteret opfindelse uden tilladelse fra patentindehaveren. Køber må ikke beholde en kopi heraf.

Leverage PolyOne’s global reach Phase 1 Phase 2 Phase 3 18-20% operating margins Invest in commercial resources I N V E S T - T O - G R O W P R O O F O F P E R F O R M A N C E PolyOne Corporation 25 Commercial Resources Operating Income ($ in millions) Operating Margins 243 340 At Acquisition Today $36 $96 At Acquisition Today 11% 20% At Acquisition Today Established Acquisitions (> 7 years) + 40% + 165% + 900 bps I N V E S T - T O - G R O W D R I V I N G T H E F U T U R E PolyOne Corporation 26 Commercial Resources Operating Income ($ in millions) Operating Margins 138 181 251 At Acquisition Today Goal $23 $25 $70 At Acquisition Today Goal 7% 8% 18-20% At Acquisition Today Goal Recent Acquisitions PolyOne Corporation 27 Average Company Size # of Possibilities Rationale $200M • • • S T R O N G P I P E L I N E D R I V E N B Y F R A G M E N T E D M A R K E T $0 $150 $300 $450 $600 $750 $900 2011 2012 2013 2014 2015 2016 2017 2018 $890M R E T U R N I N G C A S H T O S H A R E H O L D E R S O V E R $ 1 . 2 B I L L I O N S I N C E 2 0 1 1 PolyOne Corporation $0.16 $0.20 $0.24 $0.32 $0.40 $0.48 $0.54 $0.70 $0.78 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 3-Year Dividend Plan Cumulative Share Repurchases Increasing Annual Dividend 28 6.3% 14.1% 16-17% 2009 2018 Updated Expectations R O I C D R I V E S S H A R E H O L D E R R E T U R N PolyOne Corporation 29 PolyOne Corporation 30 W H Y I N V E S T I N P O L Y O N E ? T H E N E W P O L Y O N E : A S P E C I A L T Y G R O W T H C O M P A N Y       SERVICE: T H E T I M E L E S S D I F F E R E N T I A T O R PolyOne Corporation 31 T A L E N T D E V E L O P M E N T PolyOne Corporation 32 Leadership Program Participants 2012 2013 2014 2015 47 0 86 2016 2018 125 169 315 Campus Hires 2008 2011 2014 2017 0 25 90 47 PolyOne LSS Blackbelts 2008 2011 2014 2018 0 67 220 147 2018 141 A U N I Q U E C U S T O M E R E X P E R I E N C E Industrial Design IQ DESIGN LABS PolyOne Corporation 33 Material & Color Expertise Manufacturing Expertise 3 14 2014 2018 Industrial designers $0 $10M 2014 2018 $4M $80M 2014 2018 Opportunity funnel New business revenue LSS CUSTOMER FIRST PolyOne Corporation 34 Customer Projects 2014 2018 2 104 3 D P R I N T I N G B R I N G I N G N E W I D E A S T O L I F E PolyOne Corporation 35 PolyOne Corporation 36 M O N T H M O N T H M O N T H M O N T H M O N T H M O N T H 99.9% up to 24 weeks 6 hours C O L O R M A T R I X S E L E C T ™ I N N O V A T I N G W I T H P O L Y O N E PolyOne Corporation 37 SEGMENT HIGHLIGHTS C O L O R , A D D I T I V E S & I N K S EN D M A R K ET S & S O L U T I O N S PolyOne Corporation 38 Solid Colorants Performance Additives Screen Printing Inks Liquid Colorants Packaging 28% Industrial 14% Textiles 13% Wire & Cable 11% Building & Construction 10% Transportation 8% Consumer 8% Healthcare 5% Appliances 2% Electrical & Electronic 1% Operating Income & MarginRevenue by Region C O L O R , A D D I T I V E S & I N K S 2 0 1 8 R E V E N U E | O V ER $ 1 B I L L I O N $4 $25 $104 $159 0.9% 5.5% 12.2% 15.1% 2005 2009 2013 2018 PolyOne Corporation 39 Europe 35% United States 45% Asia 14% Canada 1% Mexico 3% South America 2% S P E C I A L T Y E N G I N E E R E D M A T E R I A L S EN D M A R K ET S & S O L U T I O N S PolyOne Corporation 40 Engineered Formulations Advanced Composites Thermoplastic Elastomers Consumer 21% Transportation 18% Wire & Cable 13%Healthcare 9% Industrial 9% Packaging 7% Appliance 3% Building & Construction 4% Electrical & Electronics 16% S P E C I A L T Y E N G I N E E R E D M A T E R I A L S Revenue by Region Operating Income & Margin 2 0 1 8 R EV EN U E | $ 6 4 6 M I L L I O N PolyOne Corporation 41 $21 $57 $72 0.1% 5.1% 9.3% 11.2% 2005 2009 2013 2018 Europe 28% United States 46% Asia 24% Canada 2% P E R F O R M A N C E P R O D U C T S & S O L U T I O N S EN D M A R K ET S & S O L U T I O N S PolyOne Corporation 42 Specialty Vinyl Solutions Healthcare Formulations Smart Device Materials Flame Retardant Polymers Building & Construction 28% Industrial 18% Transportation 17% Wire & Cable 16%Consumer 7% Appliance 6% Packaging 4% Electrical & Electronics 4% Asia 2% United States 78% Mexico 5% Canada 15% P E R F O R M A N C E P R O D U C T S & S O L U T I O N S Operating Income & MarginRevenue by Region 2 0 1 8 R EV EN U E | $ 7 3 6 M I L L I O N $40 $24 $56 $74 4.6% 3.6% 7.2% 10.0% 2005 2009 2013 2018 PolyOne Corporation 43 D I S T R I B U T I O N EN D M A R K ET S & S U P P L I ER S PolyOne Corporation 44 Healthcare 27% Transportation 22% Industrial 18% Consumer 12% Appliance 6% Electrical & Electronics 5% Building & Construction 5% Packaging 3% Wire & Cable 2% $20 $25 $63 $71 2.9% 4.0% 5.9% 5.6% 2005 2009 2013 2018 Operating Income & Margin2018 Revenue | $1.3 Billion http://www.polyone.com/Pages/VariationRoot.aspx O V E R V I E W O F R A W M A T E R I A L P U R C H A S E S PolyOne Corporation 45 T A R G E T E N D M A R K E T S & A P P L I C A T I O N E X A M P L E S PolyOne Corporation 46 Thermally Conductive Technologies Chemical Resistant Technologies Polymer Colorants Elastomeric Grips and Handles Structural Composites Antimicrobial Technologies Anti-Counterfeiting Technologies Target End Markets… Healthcare Catheter Technologies Under-hood Components Target End Markets… Automotive Interior Structural Components Sound & Vibration Management Roof Systems Air Management Electronics and Cameras Lighting Exterior / Interior Trim Braces & Brackets Fasteners Seals & Flaps Target End Markets… Consumer Thermally Conductive Components Polymer Colorants Elastomeric Grips and Handles Structural Composite Components Oxygen Scavenger Technologies Laser Marking Additives Antistatic Technologies UV Light Barrier Technologies Cap & Closure Colorants Process Optimization Technologies Antioxidant Technologies Density Modified Technologies Target End Markets… Packaging    Luxury Packaging GravitechTM Density Modified Polymers    Optimize Color Usage OnColorTM Super Concentrates    Combat Bacteria Formation WithStandTM Antimicrobial Technology    Medical Device Housings Chemically Resistant Engineered Polymers Color & Design Services      Outdoor Applications            Fiber Colorants Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to PolyOne shareholders, excluding special items, to assess performance and facilitate comparability of results. Adjusted EPS attributable to PolyOne common shareholders is calculated as follows: 2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016 2017 2018 Net income from continuing operations attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 Joint venture equity earnings, after tax (19.0) (14.7) (3.7) — — — — — — — Special items, before tax(1) (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 Special items, tax adjustments(1) (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) Adjusted net income from continuing operations attributable to PolyOne common shareholders $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation. (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures, including adjustments related to contingent consideration; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.

Francisco Nakasato, 1700 Bairro São Roque das Chaves Itupeva, SP 13295-000 Brasil ISO 9001:2015 O Sistema de Gestão da Qualidade é aplicável a: Certificado No: 49862 Data de Expiração Anterior: 09 Abril 2020 Data de Aprovação Original: 16 Abril 2014 Data de Certificação: 13 Abril 2020 Data Efetiva: 06 Abril 2023 Data de Expiração: 09 Abril 2026 Data de Emissão: 06 Abril 2023 Dominic Townsend, Presidente DEVELOPMENT, PRODUCTION, SALES AND TECHNICAL ASSISTANCE OF LIQUID COLORANTS, COLORS CONCENTRATES AND ADDITIVES FOR THE PLASTICS, FIBERS AND RUBBER MARKET IN GENERAL DESENVOLVIMENTO, PRODUÇÃO, VENDAS E ASSISTÊNCIA TÉCNICA DE COLORANTES LÍQUIDOS, CONCENTRADOS DE CORES E ADITIVOS PARA O MERCADO DE PLÁSTICOS, FIBRAS E BORRACHAS EM GERAL.

Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. To provide comparable results, the company references “pro forma” financial metrics, which include the business results of Avient Protective Materials for periods prior to the Acquisition Date, as if the transaction occurred on January 1, 2021 and reflect Distribution as a discontinued operation. Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 33 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.9 14.6 13.7 13.0 11.9 8.8 18.7 17.4 11.8 10.0 9.7 9.1 8.0 7.9 A vi en t (2 01 1) A vi en t (2 01 8) A vi en t (2 02 3) K W R P P G R P M A V Y F U L E C L H X L F M C A S H S C L C E E M N H U N Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. To provide comparable results, the company references “pro forma” financial metrics, which include the business results of Avient Protective Materials for periods prior to the Acquisition Date, as if the transaction occurred on January 1, 2021 and reflect Distribution as a discontinued operation. Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 37 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.9 14.6 13.7 13.0 11.9 8.8 18.7 17.4 11.8 10.0 9.7 9.1 8.0 7.9 A vi en t (2 01 1) A vi en t (2 01 8) A vi en t (2 02 3) K W R P P G R P M A V Y F U L E C L H X L F M C A S H S C L C E E M N H U N Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

ZWOLSEWEG 1, 2994 LB, BARENDRECHT, NETHERLANDS. Park, Pudong, Shanghai, China, 201203 and the sites as mentioned in the appendix accompanying this certificate has been found to conform to the Quality Management System standard: ISO 9001:2015/GB/T 19001-2016 This certificate is valid for the following scope: Design and Manufacture of Masterbatch C ertificate No: 7071-1998-AQ-RGC-RvA P lace and date: Shanghai, 30 March, 2018 Lack of fulfilment of conditions as set out in the Certification Agreement may render this Certificate invalid. ACCREDITED UNIT: DNV GL Business Assurance B.V., ZWOLSEWEG 1, 2994 LB, BARENDRECHT, NETHERLANDS.

Certificate NEU Specialty Engineered Materials Certificate Of Conformance This is to certify that the Quality Management System of: NEU Specialty Engineered Materials 15 Corporate Drive North Haven CT 06473 United States has been assessed by ABS Quality Evaluations, Inc. and found to be in conformance with the requirements set forth by: ISO 13485:2016 The Quality Management System is applicable to: Compounding, Prototype Services and Supply of Thermoplastics for the Medical Device Industry. Page 1 of 1 https://abs.zertic.com https://abs.zertic.com

主要特性 生产符合高于CAS编号级别的变更控制原则 （与MEVOPUR母粒类似），降低变更风险 不含动物源性物质和邻苯二甲酸盐 适用于吹膜、注塑、吹塑和挤出 • • • 注册药品主文件（III型） 食品接触符合FDA/EU*要求 法规支持 原材料根据以下法规测试： - ISO 10993-1 - USP第、章，包括VI级别，符合眼 科和鼻腔用药物要求 - 欧洲药典3.1.3/3.1.5（聚烯烃） - 美国药典（聚乙烯） - ICH Q3D 杂质元素 - USP和USP，透光率 • • • 载体材料 耐光性 热稳定性 产品代码颜料含量/类型 HDPE 50% TiO2 8 300°C PH00075525 LLDPE 60% TiO2 8 300°C PL00075542 LLDPE 70% TiO2 8 300°C PL00075545 PP 50% TiO2 8 300°C PP00075717 适用医疗保健使用限制—见下文。 埃万特的产品不为以下目的或用途而设计，也不会宣传或预期用于以下目的或用途： (a) 被美国食品药品监督管理局（FDA）或国际标准化组织（ISO）归类为“植入”类器械的医疗器械；或美国药典（USP）或ISO标准定义的“永久”使用器械；或 (b) 经修订的欧盟指令90/385/EEC中定义的有源植入式医疗器械；或者 (c) 经修订的欧盟指令93/42/EEC中定义的“长期”使用的医疗器械。 在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。

Zwolseweg 1, 2994 LB, Barendrecht, Netherlands. Park, Pudong, Shanghai, China, 201203 has been found to conform to the Environmental Management System standard: ISO 14001:2015 This certificate is valid for the following scope: Design and Manufacture of Masterbatch

Kalisabi No. 1, Kec. Cibodas Kecamatan Cibodas, Tangerang 15138 Indonesia Scope Category I Production of customer specific Masterbatches for Food packaging materials on the dedicated extrusion lines Normative base ISO 22000:2018 Food Safety Management Systems Requirements for any organization in the food chain Reg. no. 46391 Validity 25. 02. 2021 – 24. 02. 2024 Issue 30. 06. 2021 Swiss Madesqs.ch F.